Abbink
David Abbink, Amsterdam NL
Patent application number | Description | Published |
---|---|---|
20110238254 | SYSTEM PROVIDED WITH AN ASSISTANCE-CONTROLLER FOR ASSISTING AN OPERATOR OF THE SYSTEM, CONTROL-OPERATION ASSISTING DEVICE, CONTROL-OPERATION ASSISTING METHOD, DRIVING-OPERATION ASSISTING DEVICE, AND DRIVING-OPERATION ASSISTING METHOD - A target-travel-path generating circuit calculates a target travel path along which the controlled object can travel in the future from the current controlled object position, an ideal-control-signal calculating circuit calculates a control profile Ŝ to travel along the target travel path P, and a difference calculating circuit calculates a difference δ between the ideal control magnitude Ŝ and a current control magnitude Ŝ. An operation system assistance controller controls the operation system based on the magnitude of the calculated difference δ to assist the control operation of the operator, the control-operation-state of the operator, the environment-state, and the required operation-precision. Accordingly, it is possible to provide the operator with control operation assistance that is a function of the magnitude of the difference δ from an ideal control state, the control-operation-state of the operator, the environment-state, and the required operation-precision, and thus, a control-operation assistance control can be outputted that is suitable for the conditions that characterize the state of the operator, the environment, and the controlled object. | 09-29-2011 |
David Abbink, Delft NL
Patent application number | Description | Published |
---|---|---|
20140046503 | SYSTEM PROVIDED WITH AN ASSISTANCE-CONTROLLER FOR ASSISTING AN OPERATOR OF THE SYSTEM, CONTROL-OPERATION ASSISTING DEVICE, CONTROL-OPERATION ASSISTING METHOD, DRIVING-OPERATION ASSISTING DEVICE, AND DRIVING-OPERATION ASSISTING METHOD - A target-travel-path generating circuit calculates a target travel path along which a controlled object can travel in the future from a current controlled object position. An ideal-control-signal calculating circuit calculates a control profile to travel along the target travel path, and a difference calculating circuit calculates a difference between an ideal control magnitude and a current control magnitude. A controller controls an operation system based on a magnitude of the difference to assist a control operation and a control-operation-state of an operator, an environment-state, and a required operation-precision. The operator receives assistance corresponding to the magnitude of the difference from an ideal control state, the control-operation-state, the environment-state, and the required operation-precision. An outputted control-operation assistance control is suitable for conditions that characterize the operator state, the environment, and the controlled object. | 02-13-2014 |
Peter Abbink, Winthrop, MA US
Patent application number | Description | Published |
---|---|---|
20150246112 | REPLICATING RECOMBINANT ADENOVIRUS VECTORS, COMPOSITIONS, AND METHODS OF USE THEREOF - Replicating recombinant adenovirus vectors derived from human adenovirus serotype 26 or human adenovirus serotype 35 are described. The replicating recombinant adenovirus vectors have attenuated replicative capacity as compared to that of the corresponding wild-type adenovirus. They can be used for stable expression of heterologous genes in vivo. Also described are compositions and methods of using these recombinant adenovirus vectors to induce an immune response in a subject, and vaccinate a subject against an immunogenic human immunodeficiency virus (HIV) infection. | 09-03-2015 |
Peter Abbink, Jamaica Plain, MA US
Patent application number | Description | Published |
---|---|---|
20150291935 | RECOMBINANT ADENOVIRUSES AND USE THEREOF - The present invention relates to recombinant adenoviruses and vectors thereof. In particular, the adenoviruses are novel simian adenoviruses having a low seroprevalence and high immunogenicity relative to other adenoviruses and vectors thereof. The invention also provides methods for production of the adenoviruses and for the treatment of diseases by administering the adenoviral vector(s) to a subject (e.g., a human). | 10-15-2015 |